Simpler Grants.gov #RFA-AI-28-024

NIH Grant for Next Generation Malaria Vaccine Research and Development

This opportunity from the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), seeks to fund research and development for next generation malaria vaccines. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) - Products/Services Requested: - Basic research, discovery, and preclinical development of highly efficacious malaria vaccines - Innovative vaccine design approaches, including structure-based immunogen design and combination vaccines - Unique/Notable Requirements: - No specific OEMs or vendors are named; this is a grant for research, not a product procurement - Broad eligibility: government entities, educational institutions, nonprofits, businesses, and other organizations - No cost sharing or matching requirement - Funding instrument is a grant, not a contract or purchase order

Description

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to support basic research, discovery, and/or preclinical development of highly efficacious vaccines for malaria and potentially other mosquito-borne illnesses. The program encourages novel approaches to vaccine design that utilize recent technological innovations such as structure-based immunogen design and combination vaccines to reduce parasite infection and malaria disease burden. Eligible applicants include various government entities, educational institutions, nonprofits, businesses, and other organizations. The funding instrument type is a grant, and there is no cost sharing or matching requirement.

View original listing